BioSpace News Archive

BioMidwest

Monsanto on Track to Become Carbon Neutral, Demonstrates Environmental Benefits of Modern Agriculture

Monsanto has already reduced its carbon footprint by more than 200,000 metric tons, a reduction that is roughly equal to burning 200 million pounds less coal.

November 17, 2017

·

6 min read

Deals

Can-Fite’s Former Subsidiary OphthaliX Successfully Completes Merger With Wize Pharma

As a result of the merger, Can-Fite’s ownership of OphthaliX, immediately post-merger, became approximately 8% of the outstanding shares.

November 17, 2017

·

5 min read

Biotech Bay

Amarantus Enters Into Forbearance and Capital Restructuring Agreements With Holders of Secured Debt, Convertible Preferred Stock and Warrants

Concurrent with this announcement, the Company’s CEO will be presenting an overview of its pending Phase IIb Eltoprazine program for Parkinson’s disease levodopa-induced dyskinesia on Saturday November 18th, 2017 at 1:30pm ET during the Neuroscience Session at CNS Summit 2017.

November 17, 2017

·

11 min read

SenesTech Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common Stock

The warrants will have an exercise price of $1.50 per share, are exercisable immediately and will expire five years from the date of issuance.

November 17, 2017

·

4 min read

Philips Wins FDA Nod for Small Parts Ultrasound Tr

Policy

FDA Extends Review for Lipocine’s TLANDO; Advisory Committee Meeting Date of January 10, 2018 Remains Unchanged

The FDA has assigned a new Prescription Drug User Fee Act goal date of May 8, 2018.

November 17, 2017

·

3 min read

Business

International Stem Cell Corporation Announces Operating Results for the Three and Nine-Months ended September 30, 2017

Combined operating income for the nine months ended September 30, 2017 from our two wholly owned revenue-generating subsidiaries was $1.3 million, an increase of 30% compared to $1.0 million in the same period in 2016.

November 17, 2017

·

7 min read

Business

ViroMed Builds Team of Experts to Direct Global Drug Development and Commercialization Efforts

ViroMed announced on November 7th that it has built a global team of experts to add momentum to the global development and commercialization of VM202 by recruiting Dr. William Schmidt, Dr. Cathryn Carroll, and Dr. Marie-Laure Nevoret.

November 17, 2017

·

3 min read

Medherant Wins Excellence in Science & Technology Award

The award recognises Medherant’s rapid progress and innovation in the development of next-generation transdermal drug delivery patches.

November 17, 2017

·

1 min read

VBL Therapeutics Announces Proposed Public Offering of 2.5 Million Shares of Ordinary Shares

The company ntends to use the cash from the offering for the advancement of clinical programs, product development, and for working capital and other general corporate purposes.

November 17, 2017

·

5 min read

Drug Development

Agios Presents Updated Phase I Data from Dose Expansion Cohort of Ivosidenib (AG-120) in Patients With IDH1 Mutant Positive Glioma

The data were presented today in an oral presentation at the Society for Neuro-Oncology Annual Meeting in San Francisco.

November 17, 2017

·

9 min read